Previous Close | 2.15 |
1-Year Change | -54.74% |
6-Months Change | 15.59% |
3-Months Change | 32.72% |
Moving Avg (50d) | 1.9943 |
Moving Avg (200d) | 1.845 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 52.7M |
Beta (3-Years) | 1.11 |
Revenue Growth (ttm) | 111.62% |
Net Profit Margin (ttm) | -272.67% |
Return On Assets (ttm) | -45.4% |
EPS (ttm) | -2.32 |
PE Ratio (ttm) | -0.93 |
Dividend Yield | 0% |
Asset Description: | Aadi Bioscience, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
2.264 | 2.331 | 2.375 | 2.442 | 2.553 | 2.664 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |